April 28, 2023 by admin aurigene Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase
April 28, 2023 by admin aurigene Peptide and peptide-inspired checkpoint inhibitors: Protein fragments to cancer immunotherapy
April 28, 2023 by admin aurigene PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
April 28, 2023 by admin aurigene Orally bioavailable SMARCA2 degraders with exceptional selectivity and potency
April 28, 2023 by admin aurigene Evaluation of AU-18069, a novel small molecule CBP/p300 bromodomain inhibitor for the treatment of cancers
April 28, 2023 by admin aurigene Novel, potent and orally bioavailable small molecule CD73 inhibitors for cancer immunotherapy
April 28, 2023 by admin aurigene Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders
April 28, 2023 by admin aurigene Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
